BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29664030)

  • 1. Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
    Pereira P; Kapoor A; Sinha A; Agarwal SK; Pande S; Khanna R; Srivastava N; Kumar S; Garg N; Tewari S; Goel P
    Indian J Med Res; 2017 Dec; 146(6):722-729. PubMed ID: 29664030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
    Hlatky MA; Solomon MD; Shilane D; Leong TK; Brindis R; Go AS
    J Am Coll Cardiol; 2013 Jan; 61(3):295-301. PubMed ID: 23246391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
    Kawashima H; Serruys PW; Ono M; Hara H; O'Leary N; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Sharif F; McEvoy JW; Onuma Y;
    J Am Coll Cardiol; 2021 Jul; 78(1):27-38. PubMed ID: 34210411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ; Kibiro M; Eichhöfer J; Curzen NP
    Postgrad Med J; 2005 Jun; 81(956):401-3. PubMed ID: 15937208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Trends in Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry.
    Riley RF; Don CW; Aldea GS; Mokadam NA; Probstfield J; Maynard C; Goss JR
    J Am Heart Assoc; 2012 Aug; 1(5):e002733. PubMed ID: 26600570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease.
    Jia S; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Yuan J; Song L
    Circ J; 2020 Sep; 84(10):1718-1727. PubMed ID: 32848116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry.
    Okrainec K; Pilote L; Platt R; Eisenberg MJ
    Can J Cardiol; 2006 Aug; 22(10):841-7. PubMed ID: 16957801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery.
    Filion KB; Pilote L; Rahme E; Eisenberg MJ
    J Card Surg; 2008; 23(3):209-15. PubMed ID: 18435634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention.
    Ardati AK; Pitt B; Smith DE; Aronow HD; Share D; Moscucci M; Chetcuti S; Grossman PM; Gurm HS
    Am Heart J; 2013 May; 165(5):778-84. PubMed ID: 23622915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes N; Gersh BJ; Soares PR; Ribeiro EE; Pereira AC; Favarato D; Rocha AS; Hueb AC; Ramires JA
    Circulation; 2010 Sep; 122(10):949-57. PubMed ID: 20733102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study.
    Wijeysundera HC; Bennell MC; Qiu F; Ko DT; Tu JV; Wijeysundera DN; Austin PC
    J Gen Intern Med; 2014 Jul; 29(7):1031-9. PubMed ID: 24610309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical therapy in revascularized coronary artery disease patients].
    Liu XH; DU X; Kang JP; Lü Q; Zhang Q; Lü SZ; Chen F; Ma CS
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):236-9. PubMed ID: 18361833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.
    Varghese I; Samuel J; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(2):103-9. PubMed ID: 19327672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of multiple chronic total occlusions in coronary arteries according to three therapeutic strategies: Bypass surgery, percutaneous intervention and medication.
    Kim BS; Yang JH; Jang WJ; Song YB; Hahn JY; Choi JH; Kim WS; Lee YT; Gwon HC; Lee SH; Choi SH
    Int J Cardiol; 2015 Oct; 197():2-7. PubMed ID: 26113468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.